A Study of LY317615 in Patients With Brain Tumors
NCT00190723
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Glioma
Interventions
DRUG:
Enzastaurin
Sponsor
Eli Lilly and Company